The in vitro effects of graded concentrations of niridazole (Ambilhar) and stibocaptate (Astiban) on the glycolytic pathway and motility of the Egyptian strain of Schistosoma mansoni.
D000818:Animals; D000965:Antimony / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005947:Glucose / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects*; D007773:Lactates / Q000378:metabolism; D008124:Locomotion / Q000187:drug effects*; D051379:Mice; D009560:Niridazole / Q000008:administration & dosage / Q000494:pharmacology*; D012550:Schistosoma mansoni / Q000187:drug effects* / Q000378:metabolism; D013386:Succinates / Q000494:pharmacology*; D013440:Sulfides / Q000494:pharmacology
D007773:Lactates; D013386:Succinates; D013440:Sulfides; D000965:Antimony; D005947:Glucose; D009560:Niridazole